HomeSILVERTUC › Filing
🔔 Get instant alerts when SILVERTUC files quarterly results on BSE Start free trial →

Outcome of Board Meeting

Filed: 30 Jul 2026, 18:51 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Un-audited standalone and consolidated financial results approved for Q1 ended June 30, 2026 - Board recommended final dividend of ₹0.10/share (5%) for FY26, subject to shareholder approval - Re-appointment recommended for Whole Time Directors Vipul Thakkar and Minesh Doshi - Independent Director Piyushkumar Sinha recommended for second 5-year term from Aug 12, 2026 - Investment approval up to Rs 10 Cr under Companies Act - 32nd AGM scheduled for Aug 24, 2026 with remote e-voting from Aug 21-23 - Record date for dividend fixed at Aug 17, 2026, subject to approval
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SILVERTUC — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SILVERTUC to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Silver Touch Technologies Limited

Important. The summary above is generated automatically from Silver Touch Technologies Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.